You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4926 to 4950 of about 5880
Next 25
03/13/2005
Fundraising For Brain Tumor Research page!
03/11/2005
Added Link to: Skull Base Institute
03/10/2005
New hope against brain tumors
Inotek Pharmaceuticals Announces Commencement of Enrollment in Phase 1b/2a Trial for Glioblastoma Multiforme
Recurrent low-grade gliomas: the role of fractionated stereotactic re-irradiation.
Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma.
A Phase II trial of paclitaxel and topotecan with filgrastim in patients with recurrent or refractory glioblastoma multiforme or anaplastic astrocytoma.
UKT-04 trial of continuous metronomic low-dose chemotherapy with methotrexate and cyclophosphamide for recurrent glioblastoma.
Gefitinib (`Iressa`, ZD1839) is active against brain metastases in a 77 year old patient.
Limited efficacy of gene transfer in herpes simplex virus-thymidine kinase/ganciclovir gene therapy for brain tumors.
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy
Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.
Resection of brain metastases previously treated with stereotactic radiosurgery.
Surgical outcomes of cerebellar tumors in children.
03/08/2005
Added Link to: The Fruit of Hope
03/04/2005
Diffusion Pharmaceuticals Announces Strategic Alliance To Develop New Cancer Therapies
03/03/2005
One of our long term survivors, Steven M, died recently. I removed his survivor page. He was diagnosed with a brainstem glioma in 1992.
Scorpion venom takes on tumors A protein from the poison helps deliver radioactive molecules to cancer cells.
Brain tumor with dismal prognosis in infants can be cured in older children
03/02/2005
Parents face choice in treating childhood cancer
03/01/2005
Myriad Initiates Phase 1 Trial of MPC-6827 in Metastatic Brain Cancer
02/28/2005
Breaking News - FDA Clears Oncolytics Brain-Tumor Trial
YM BioSciences and Oncoscience Report Response Rate of 35.3% in Pediatric Glioma - TheraCIM h-R3 (nimotuzumab) Phase II Results Presented at European High Grade Glioma Conference -
Chugai Pharmaceutical`s Antitumor Agent Natulan Now Available for Treating Glioma 28 Feb 2005
02/27/2005
15 Kilometer Run Benefits Brain Tumor Charities (Long Island, NY)